Supernus Pharmaceuticals Income Taxes 2011-2024 | SUPN

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Revenue Gross Profit Operating Income EBITDA Net Income Shares Outstanding

Supernus Pharmaceuticals income taxes from 2011 to 2024. Income taxes can be defined as the total amount of income tax expense for the given period.

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Revenue Gross Profit Operating Income EBITDA Net Income Shares Outstanding

Supernus Pharmaceuticals income taxes from 2011 to 2024. Income taxes can be defined as the total amount of income tax expense for the given period.

Related Stocks
Company Name	Market Cap
Teva Pharmaceutical Industries (TEVA)	$24.9B
Dr Reddy's Laboratories (RDY)	$12.6B
BridgeBio Pharma (BBIO)	$6.8B
Bausch Health Cos (BHC)	$2.8B
Amphastar Pharmaceuticals (AMPH)	$1.7B
Personalis (PSNL)	$396M
Taysha Gene Therapies (TSHA)	$314M
Assembly Biosciences (ASMB)	$95M
Sol-Gel Technologies (SLGL)	$25M
Evoke Pharma (EVOK)	$6M
Teligent (TLGT)	$0M